2016
The Role of Proliferation in Determining Response to Neoadjuvant Chemotherapy in Breast Cancer: A Gene Expression–Based Meta-Analysis
Stover DG, Coloff JL, Barry WT, Brugge JS, Winer EP, Selfors LM. The Role of Proliferation in Determining Response to Neoadjuvant Chemotherapy in Breast Cancer: A Gene Expression–Based Meta-Analysis. Clinical Cancer Research 2016, 22: 6039-6050. PMID: 27330058, PMCID: PMC5161615, DOI: 10.1158/1078-0432.ccr-16-0471.Peer-Reviewed Original ResearchConceptsTriple-negative breast cancerNeoadjuvant chemotherapyPathologic complete responseBreast cancerGene expression signaturesComplete responseExpression signaturesPrimary breast cancer biopsiesImmune activation signatureBreast cancer biopsiesRole of proliferationClinicopathologic characteristicsSignature scoreImmune activityCancer biopsiesPAM50 subtypesBreast tumorsProliferation differencesCancerActivation signatureNeoadjuvant chemosensitivityChemosensitivityTumorsDNA damageScores
2013
Quality of life and symptoms in male breast cancer survivors
Ruddy KJ, Giobbie-Hurder A, Giordano SH, Goldfarb S, Kereakoglow S, Winer EP, Partridge AH. Quality of life and symptoms in male breast cancer survivors. The Breast 2013, 22: 197-199. PMID: 23313328, DOI: 10.1016/j.breast.2012.12.014.Peer-Reviewed Original ResearchConceptsMale breast cancer survivorsBreast cancer survivorsQuality of lifeCancer survivorsProstate Cancer Index CompositeCancer Therapy-BreastFACT-B scoresHormonal scoresHormonal symptomsSymptom burdenBreast cancerStage 0Depression ScaleFunctional assessmentHospitalized AnxietyMale survivorsSymptomsSurvivorsSexual scaleOverall qualityScoresPatientsCancer
2007
How well do standard prognostic criteria predict oncotype DX (ODX) scores?
Kamal A, Loprinzi C, Reynolds C, Dueck A, Geiger X, Ingle J, Carlson R, Hobday T, Winer E, Perez E, Goetz M. How well do standard prognostic criteria predict oncotype DX (ODX) scores? Journal Of Clinical Oncology 2007, 25: 576-576. DOI: 10.1200/jco.2007.25.18_suppl.576.Peer-Reviewed Original ResearchODX scoresPrognostic criteriaBreast cancerExpert breast pathologistsMayo Clinic patientsOncotype DX scoreAssessment of ERAdjuvant chemotherapyIntermediate riskBreast pathologistsClinic patientsTumor sizeAcademic oncologistsTumor gradeHigh riskTumor slidesStandardized criteriaClinical casesPatientsOncologistsGene expression profilingSignificant financial relationshipChemotherapyODXScores